Rhenman & Partners Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-65,698
Closed -$6.2M 100
2019
Q1
$6.2M Sell
65,698
-150,000
-70% -$13.1M 0.73% 54
2018
Q4
$13.8M Buy
215,698
+35,000
+19% +$2.58M 1.58% 29
2018
Q3
$16.2M Sell
180,698
-30,000
-14% -$2.65M 1.62% 27
2018
Q2
$16.7M Sell
210,698
-85,714
-29% -$7.12M 1.71% 25
2018
Q1
$26.4M Buy
296,412
+135,000
+84% +$13M 3.26% 2
2017
Q4
$16.8M Buy
161,412
+9,412
+6% +$1.06M 2.28% 11
2017
Q3
$22.2M Buy
152,000
+10,000
+7% +$1.36M 2.83% 6
2017
Q2
$18.4M Buy
142,000
+49,000
+53% +$6M 2.65% 5
2017
Q1
$11.6M Hold
93,000
1.83% 17
2016
Q4
$10.8M Sell
93,000
-93,000
-50% -$10.4M 2.06% 16
2016
Q3
$19.4M Sell
186,000
-13,000
-7% -$1.41M 3.09% 4
2016
Q2
$19.6M Buy
199,000
+79,000
+66% +$8.17M 3.49% 3
2016
Q1
$12M Buy
120,000
+16,000
+15% +$1.65M 2.38% 8
2015
Q4
$12.5M Sell
104,000
-32,000
-24% -$3.7M 1.88% 15
2015
Q3
$14.7M Sell
136,000
-1,000
-0.7% -$124K 2.35% 9
2015
Q2
$15.9M Sell
137,000
-14,000
-9% -$1.6M 1.9% 10
2015
Q1
$17.4M Sell
151,000
-31,000
-17% -$3.7M 2.94% 3
2014
Q4
$20.4M Buy
182,000
+102,000
+128% +$10.8M 5.9% 1
2014
Q3
$7.58M Sell
80,000
-76,781
-49% -$6.93M 2.22% 8
2014
Q2
$13.5M Buy
156,781
+39,999
+34% +$3.04M 4% 5
2014
Q1
$8.15M Buy
116,782
+18,782
+19% +$1.49M 2.45% 9
2013
Q4
$8.28M Buy
+98,000
New +$7.75M 3.24% 2

Other funds holding CELG

Rhenman & Partners Asset Management's CELG Position: Q2 2019 in Review

Rhenman & Partners Asset Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 65,698 shares — an estimated $6.2M sold.

Rhenman & Partners Asset Management first reported a position in CELG in Q4 2013 and held it in 22 quarters. The position peaked at $26.4M in Q1 2018. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Rhenman & Partners Asset Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 65,698 Celgene Corp shares in Q2 2019, an estimated $6.2M.
  • Rhenman & Partners Asset Management first reported a position in Celgene Corp in Q4 2013 and held it in 22 quarters.
  • Rhenman & Partners Asset Management's Celgene Corp position peaked at $26.4M in Q1 2018.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2019, filed 22 Jul 2019.